Although all these reports (Table 1) shed some novel light on the intricate layers contributing to the regulation of SMYD3 levels, the clinical relevance of SMYD3 over-expression in cancer warrants a more comprehensive understanding of the underlying molecular mechanisms. This evidence concerns the gene SMYD3 and cancer.